'Weight-loss drug has been life-changing for me'
Nikki Laine has been taking the weight-loss drug Mounjaro for just over three weeks and has described it as "life-changing" after losing 1st st and 2lb (7.6kg). Mounjaro – also known as Tirzepatide – is an injectable prescription which contributes to weight loss when taken alongside a healthy diet and regular exercise.
This weight loss drug reduces heart failure risk
A groundbreaking study shows how Zepbound, a popular weight loss medication, could become a key treatment for heart failure patients while reducing death rates.
Zepbound for Weight Loss: What to Know About This Weight Loss Drug
For years, conventional wisdom has been that weight loss is a matter of willpower. Those who are overweight or obese just need to try harder to eat less and exercise more. But while diet and
US FDA Says Shortage of Novo's Weight-Loss Drug Resolved
All doses of Novo's diabetes treatment Ozempic and weight-loss drug Wegovy were listed as available on the FDA's website in October, but the treatments were not taken off the offi
Hims Stock Crashes After FDA Resolves Weight-Loss Drugs Shortage
Hims stock dropped sharply Friday after the U.S. Food and Drug Administration said the shortage of widely-used weight-loss and diabetes drugs has been resolved. The FDA website indicated that the shortage of Novo Nordisk's Ozempic and Wegovy has ended.
Novo Nordisk Shares Rise After FDA Clears Shortage of Anti-Obesity Drugs
Shares of obesity-drug maker Novo Nordisk rose Friday after the Food and Drug Administration declared that the company’s popular medications Ozempic and Wegovy were no longer in shortage. A shortage o
Ozempic and Wegovy shortage ends, setting up weight loss drug showdown
Ozempic and Wegovy, the popular GLP-1 drugs for diabetes and weight loss, are no longer in short supply, the FDA declared Friday. Why it matters: That's good news for Novo Nordisk (whose stock rose 5% Friday) and potentially bad news for Hims & Hers (which fell 26%).
Hims & Hers Stock Drops as FDA Says Ozempic and Wegovy No Longer in Short Supply
Key Takeaways Hims & Hers Health shares swooned after the Food & Drug Administration said the active ingredient in Ozempic and Wegovy is no longer in short supply.The company makes compounded versions of weight-loss drugs under an FDA rule that applies when the originals are difficult to obtain.
The Ozempic shortage is over, a big threat to off-brand weight loss drug sellers
The shortage of Novo Nordisk’s (NVO) blockbuster diabetes and weight-loss drugs is officially over, according to the U.S. Food and Drug Administration (FDA).
Are Weight Loss Injections Safe? What to Know Before Starting One
Weight loss injections have become incredibly popular in the last year or so. In fact, these medications are so widely used ...
FiercePharma1d
Novo Nordisk's semaglutide shortage officially concludes in the US, spelling major threat for weight loss drug compounders
Following the resolution of Eli Lilly’s tirzepatide shortage in October, the FDA has officially declared an end to the supply ...
Prevention on MSN9d
Scientists Explain ‘Ozempic Blindness,’ Link Between Sudden Vision Loss and Weight Loss Drugs
Research links weight loss medications like Ozempic and Zepbound to certain serious eye conditions.
Fox News7d
Weight-loss, diabetes drugs linked to vision problems in small study
Popular drugs for diabetes and weight loss could have an unexpected side ... and Mounjaro and Zepbound, which contain tirzepatide. In the study, nine patients who were using a GLP-1 developed ...
ConsumerAffairs9d
7 weight loss pills that actually work
The FDA has approved multiple weight loss medications. These include bupropiron-naltrexone, orlistat, phentermine-topiramate, liraglutide, semaglutide, tirzepatide and setmelanotide. Where can I ...
AOL9d
Scientists Find Link Between Weight Loss Drugs and Blindness
Research links weight loss medications like Ozempic and Zepbound to certain serious eye conditions. This association is being called “Ozempic blindness.” Experts are not entirely clear why ...
Trump, RFK Jr. go after antidepressants, weight loss drugs. Here's what the science says
President Donald Trump and HHS Secretary Robert F. Kennedy Jr. said they will be studying the "threat" to children posed by ...
Weight loss jabs CAN make you go blind by causing an ‘eye stroke’, study of 37million finds
WEIGHT loss jabs could raise the risk of a “potentially blinding condition” known as an “eye stroke”, researchers have warned ...